Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem Melphalan and TMI with Lenalidomide Maintenance in Multiple Myeloma
NCT00112827Phase 2Completed
- Sponsor
- City of Hope
- Start
- Nov 2004
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan, lenalidomide in multiple myeloma (MM), sponsored by City of Hope. Started Nov 2004; status: completed.
02
Drugs
melphalanlenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00112827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112827.